-

Olympus Adopts AcuityMD Across the Enterprise to Power an Expanding Omnichannel Engagement Strategy

BOSTON--(BUSINESS WIRE)--AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, has expanded its partnership with Olympus Corporation, a top 20 MedTech company that delivers advanced diagnostic, therapeutic, and minimally invasive procedures to healthcare professionals (HCPs). Olympus is leveraging AcuityMD not only to expand business opportunities but also to continue building its omnichannel strategy and improve the customer experience with personalized engagement.

Olympus sought an industry-specific commercial solution that combines accurate data, analytics, and customer relationship management functionality in one easy-to-use platform. The company adopted AcuityMD’s Targeting Module in 2020 for their Surgical Solutions division and quickly identified new HCPs that can benefit from its products. Olympus is now expanding its use of AcuityMD’s Targeting Module across its Urology, Gastroenterology, and Respiratory business units and is using the platform to further build its omnichannel engagement strategy.

“The customer is at the center of everything we do,” said Suzan Morgan, head of omnichannel strategy at Olympus. “AcuityMD’s platform not only makes it faster to identify physicians whose patients could benefit from Olympus solutions, but it also enables more personalized engagement in more accessible ways. For instance, our sales reps get rich insights from the system to better prepare for business review meetings and ensure a relevant discussion that benefits each physician.”

“We’ve built a true partnership with AcuityMD over the years,” said Michael Fleming, vice president of commercial operations at Olympus. “AcuityMD has been instrumental in streamlining our sales operations and building our pipeline, and we are excited to expand the relationship.”

AcuityMD is filling a void for a data-driven commercialization platform that helps MedTech companies identify high-value opportunities to deliver their innovative products that improve and save lives. MedTech companies have traditionally relied on one-size-fits-all CRM software coupled with cumbersome data exports to reach potential customers. AcuityMD’s platform transforms large volumes of healthcare data, such as procedural volumes, where surgeons operate, and peer networks, into intuitive workflows that prioritize sales efforts and align with the industry’s commercialization process.

"It is especially rewarding to see how our platform has positively impacted Olympus’ sales performance and omnichannel goals over the past months, and we are excited to grow with them,” said Michael Monovoukas, CEO and co-founder of AcuityMD. “With this expansion, we aim to unlock even greater efficiencies for Olympus and continue to streamline the process of bringing their live-saving innovations to patients.”

Olympus will be presenting at AcuityMD’s first annual conference, Flywheel, September 26 in Boston. For more information, contact lbarbadora@barbadoraink.com.

About AcuityMD

AcuityMD is a leading technology partner to the commercial MedTech industry. Thousands of sales and marketing professionals use AcuityMD’s commercial platform to identify target markets, surface top opportunities, and grow their business. With customers ranging from pre-commercial to enterprise, AcuityMD is committed to providing MedTech companies with unparalleled visibility to accelerate adoption of medical technology.

Contacts

Lisa Barbadora, Barbadora INK for AcuityMD
+1 (610) 420-3413
lbarbadora@barbadoraink.com

AcuityMD


Release Versions

Contacts

Lisa Barbadora, Barbadora INK for AcuityMD
+1 (610) 420-3413
lbarbadora@barbadoraink.com

More News From AcuityMD

New Report Shows Increase in Colorectal Screenings at Ambulatory Surgery Centers (ASCs) Versus Hospitals

BOSTON--(BUSINESS WIRE)--AcuityMD, the intelligence platform for MedTech, announced data revealing increased access to colorectal screening and early treatment at ambulatory surgery centers (ASCs). Across the U.S., the majority of all endoscopic colorectal procedures are now performed in ASCs, lowering barriers to care for patients who might delay or avoid screening. ASCs handled nearly 9 million endoscopic colorectal procedures in 2024 alone, a 50% volume increase since 2018. Endoscopic exams...

AcuityMD Announces AcuityMD for Salesforce on Salesforce AppExchange

BOSTON--(BUSINESS WIRE)--AcuityMD today announced it has launched AcuityMD for Salesforce on Salesforce AppExchange, the leading enterprise marketplace for partner apps and experts, empowering customers to integrate AcuityMD’s platform directly with Salesforce to help commercial teams identify opportunities, research and prioritize targets, and hit sales goals faster. AcuityMD combines accurate and precise data, AI-powered insights, and intuitive workflows to help commercial teams move faster a...

Electromedical Products International (EPI) Expands Access of Unique Medical Technology to Veterans Experiencing Anxiety, Insomnia, Pain

BOSTON--(BUSINESS WIRE)--In recognition of Veterans Day, AcuityMD announces its partnership with Electromedical Products International (EPI) to drive access to Alpha-Stim®, a non-invasive, FDA-cleared device that uses cranial electrotherapy stimulation (CES) and microcurrent electrical therapy (MET) to treat anxiety, insomnia, and pain for U.S. military veterans. While available to all patients diagnosed with these conditions, Alpha-Stim is uniquely appealing to veterans who may have concerns w...
Back to Newsroom